Balancing Structure and Learning in an Open Prison

Leira Prison is a branch of Trondheim Prison, functioning as a relatively small,open prison with a maximum capacity of only 29 inmates. Leira Prison appliesthe method ‘consequence pedagogy.’ This article aims to pinpoint howconsequence pedagogy is executed at Leira. 50% of the Leira inmates arereleased back into society, while new ones enter the prison. It is thereforeinteresting to see how they balance structure and at the same time adjust tochanges, enabling Leira Prison to continue as a learning organization. This articleidentifies three items, consequence pedagogy and the view of humans,maintenance of the philosophy and coherence in the community, and selfregulationof justice through interaction. The use of consequence pedagogyis deeply aligned to their positive view of humans and has generated a constructiveorganization based on empowerment and involvement of both staffand inmates. Consequently, management, staff and inmates maintain thephilosophy of consequence pedagogy through interaction and self-regulation.However, questions regarding the fundamentals of the consequence pedagogyare not raised

3D Masked Modelling Advances Lesion Classification in Axial T2w Prostate MRI

Masked Image Modelling (MIM) has been shown to be an efficient self-supervised learning (SSL) pre-training paradigm when paired with transformer architectures and in the presence of a large amount of unlabelled natural images. The combination of the difficulties in accessing and obtaining large amounts of labeled data and the availability of unlabelled data in the medical imaging domain makes MIM an interesting approach to advance deep learning (DL) applications based on 3D medical imaging data. Nevertheless, SSL and, in particular, MIM applications with medical imaging data are rather scarce and there is still uncertainty around the potential of such a learning paradigm in the medical domain. We study MIM in the context of Prostate Cancer (PCa) lesion classification with T2 weighted (T2w) axial magnetic resonance imaging (MRI) data. In particular, we explore the effect of using MIM when coupled with convolutional neural networks (CNNs) under different conditions such as different masking strategies, obtaining better results in terms of AUC than other pre-training strategies like ImageNet weight initialization.publishedVersio

A Tale of Two Transcriptions : Machine-Assisted Transcription of Historical Sources

This article is part of the "Norwegian Historical Population Register" project financed by the Norwegian Research Council (grant # 225950) and the Advanced Grand Project "Five Centuries of Marriages"(2011-2016) funded by the European Research Council (# ERC 2010-AdG_20100407)This article explains how two projects implement semi-automated transcription routines: for census sheets in Norway and marriage protocols from Barcelona. The Spanish system was created to transcribe the marriage license books from 1451 to 1905 for the Barcelona area; one of the world's longest series of preserved vital records. Thus, in the Project "Five Centuries of Marriages" (5CofM) at the Autonomous University of Barcelona's Center for Demographic Studies, the Barcelona Historical Marriage Database has been built. More than 600,000 records were transcribed by 150 transcribers working online. The Norwegian material is cross-sectional as it is the 1891 census, recorded on one sheet per person. This format and the underlining of keywords for several variables made it more feasible to semi-automate data entry than when many persons are listed on the same page. While Optical Character Recognition (OCR) for printed text is scientifically mature, computer vision research is now focused on more difficult problems such as handwriting recognition. In the marriage project, document analysis methods have been proposed to automatically recognize the marriage licenses. Fully automatic recognition is still a challenge, but some promising results have been obtained. In Spain, Norway and elsewhere the source material is available as scanned pictures on the Internet, opening up the possibility for further international cooperation concerning automating the transcription of historic source materials. Like what is being done in projects to digitize printed materials, the optimal solution is likely to be a combination of manual transcription and machine-assisted recognition also for hand-written sources

Occode: an end-to-end machine learning pipeline for transcription of historical population censuses

Machine learning approaches achieve high accuracy for text recognition and are therefore increasingly used for the transcription of handwritten historical sources. However, using machine learning in production requires a streamlined end-to-end machine learning pipeline that scales to the dataset size, and a model that achieves high accuracy with few manual transcriptions. In addition, the correctness of the model results must be verified. This paper describes our lessons learned developing, tuning, and using the Occode end-to-end machine learning pipeline for transcribing 7,3 million rows with handwritten occupation codes in the Norwegian 1950 population census. We achieve an accuracy of 97% for the automatically transcribed codes, and we send 3% of the codes for manual verification. We verify that the occupation code distribution found in our result matches the distribution found in our training data which should be representative for the census as a whole. We believe our approach and lessons learned are useful for other transcription projects that plan to use machine learning in production. The source code is available at: https://github.com/uit-hdl/rhd-code

The activity of pregnancy-associated plasma protein A (PAPP-A) as expressed by immunohistochemistry in atherothrombotic plaques obtained by aspiration thrombectomy in patients presenting with a ST-elevation myocardial infarction: a brief communication

<p>Abstract</p> <p>Background</p> <p>The expression of pregnancy-associated plasma protein A (PAPP-A) was identified by immunohistochemistry (IHC) in culprit atherothrombotic plaque specimens harvested from patients admitted with ST-segment elevation myocardial infarction (STEMI).</p> <p>Methods</p> <p>The atherothrombotic samples were collected from a consecutive cohort consisting of 20 individuals admitted with STEMI to Stavanger University Hospital, Norway, from 2005-2006, presenting angiographically with an acute thrombotic occlusion of a coronary artery characterized by TIMI flow 0. The atherothrombotic plaques were obtained by aspiration thrombectomy during percutaneous coronary intervention within 12 hours from the onset of symptoms and prepared for IHC analysis.</p> <p>Results</p> <p>In the IHC analysis staining for PAPP-A occurred in the extracellular matrix of the plaques and no evidence of staining for PAPP-A was found in the thrombi.</p> <p>Conclusion</p> <p>Our results indicate that in vivo PAPP-A is strongly expressed in atherothrombotic plaques harvested from patients admitted with STEMI, as documented by IHC.</p> <p>Trial registration</p> <p><email>[email protected]</email></p

Angiopoietin-2 and angiopoietin-like 4 protein provide prognostic information in patients with suspected acute coronary syndrome

Background Plasma levels of angiopoietin-2 (ANGPT2) and angiopoietin-like 4 protein (ANGPTL4) reflect different pathophysiological aspects of cardiovascular disease. We evaluated their association with outcome in a hospitalized Norwegian patient cohort (n = 871) with suspected acute coronary syndrome (ACS) and validated our results in a similar Argentinean cohort (n = 982). Methods A cox regression model, adjusting for traditional cardiovascular risk factors, was fitted for ANGPT2 and ANGPTL4, respectively, with all-cause mortality and cardiac death within 24 months and all-cause mortality within 60 months as the dependent variables. Results At 24 months follow-up, 138 (15.8%) of the Norwegian and 119 (12.1%) of the Argentinian cohort had died, of which 86 and 66 deaths, respectively, were classified as cardiac. At 60 months, a total of 259 (29.7%) and 173 (17.6%) patients, respectively, had died. ANGPT2 was independently associated with all-cause mortality in both cohorts at 24 months [hazard ratio (HR) 1.27 (95% confidence interval (CI), 1.08–1.50) for Norway, and HR 1.57 (95% CI, 1.27–1.95) for Argentina], with similar results at 60 months [HR 1.19 (95% CI, 1.05–1.35) (Norway), and HR 1.56 (95% CI, 1.30–1.88) (Argentina)], and was also significantly associated with cardiac death [HR 1.51 (95% CI, 1.14–2.00)], in the Argentinean population. ANGPTL4 was significantly associated with all-cause mortality in the Argentinean cohort at 24 months [HR 1.39 (95% CI, 1.15–1.68)] and at 60 months [HR 1.43 (95% CI, 1.23–1.67)], enforcing trends in the Norwegian population. Conclusions ANGPT2 and ANGPTL4 were significantly associated with outcome in similar ACS patient cohorts recruited on two continents.publishedVersio

A history of late and very late stent thrombosis is not associated with increased activation of the contact system, a case control study

Background: The pathophysiological pathways resulting in Late Stent Thrombosis (LST) remain uncertain. Findings from animal studies indicate a role of the intrinsic coagulation pathway in arterial thrombus formation, while clinical studies support an association with ischemic cardiovascular disease. It is currently unknown whether differences in the state of the contact system might contribute to the risk of LST or Very Late Stent Thrombosis (VLST). We assessed the relation between levels of several components involved in the contact system and a history of LST and VLST, termed (V)LST in a cohort of 20 patients as compared to a matched control group treated with PCI. Methods and Results: Activated factor XII (FXIIa), FXII zymogen (FXII), FXIIa-C1-esterase inhibitor (C1-inhibitor), Kallikrein-C1-inhibitor, FXIa-C1-inhibitor and FXIa-α1-antitrypsin (AT-inhibitor) complexes were measured by Enzyme-linked immunosorbent assy (ELISA) methodology. Cases and controls showed similar distributions in sex, age, baseline medications and stent type. Patients with a history of (V)LST had a significantly greater stent burden and a higher number of previous myocardial infarctions than the control patients. There were no significant between-group differences in the plasma levels of the components of the contact system. Conclusion: In a cohort of patients with a history of (V)LST, we did not observe differences in the activation state of the intrinsic coagulation system as compared to patients with a history of percutaneous coronary intervention without stent thrombosis

Humoral immunity to SARS-CoV-2 mRNA vaccination in multiple sclerosis: the relevance of time since last rituximab infusion and first experience from sporadic revaccinations

Introduction The effect of disease-modifying therapies (DMT) on vaccine responses is largely unknown. Understanding the development of protective immunity is of paramount importance to fight the COVID-19 pandemic. Objective To characterise humoral immunity after mRNA-COVID-19 vaccination of people with multiple sclerosis (pwMS). Methods All pwMS in Norway fully vaccinated against SARS-CoV-2 were invited to a national screening study. Humoral immunity was assessed by measuring anti-SARS-CoV-2 SPIKE RBD IgG response 3–12 weeks after full vaccination, and compared with healthy subjects. Results 528 pwMS and 627 healthy subjects were included. Reduced humoral immunity (anti-SARS-CoV-2 IgG <70 arbitrary units) was present in 82% and 80% of all pwMS treated with fingolimod and rituximab, respectively, while patients treated with other DMT showed similar rates as healthy subjects and untreated pwMS. We found a significant correlation between time since the last rituximab dose and the development of humoral immunity. Revaccination in two seronegative patients induced a weak antibody response. Conclusions Patients treated with fingolimod or rituximab should be informed about the risk of reduced humoral immunity and vaccinations should be timed carefully in rituximab patients. Our results identify the need for studies regarding the durability of vaccine responses, the role of cellular immunity and revaccinations. This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.publishedVersio

July 2017 ENCALS statement on edaravone

Peer reviewe